Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-690,002
Closed -$852K 584
2022
Q4
$852K Sell
690,002
-1,143,816
-62% -$1.57M 0.09% 106
2022
Q3
$3.36M Hold
1,833,818
0.32% 44
2022
Q2
$4.56M Buy
1,833,818
+135,400
+8% +$457K 0.44% 46
2022
Q1
$7.4M Sell
1,698,418
-1,096,400
-39% -$4.27M 0.71% 32
2021
Q4
$10.8M Hold
2,794,818
0.98% 21
2021
Q3
$11.3M Buy
2,794,818
+42,482
+2% +$180K 0.53% 28
2021
Q2
$14M Buy
2,752,336
+794,818
+41% +$3.88M 0.73% 24
2021
Q1
$8.84M Buy
1,957,518
+1,111,558
+131% +$4.81M 0.61% 18
2020
Q4
$3.19M Buy
845,960
+10,588
+1% +$32.4K 0.29% 38
2020
Q3
$2.44M Buy
835,372
+17,620
+2% +$55.6K 0.4% 42
2020
Q2
$2.42M Buy
817,752
+129,044
+19% +$485K 0.4% 46
2020
Q1
$2.73M Buy
+688,708
New +$3.46M 0.63% 36

Other funds holding BWAY

Cowen and Company's BWAY Position: Q1 2023 in Review

Cowen and Company sold out of Brainsway (BWAY) in Q1 2023, closing a stake of 690,002 shares — an estimated $852K sold.

Cowen and Company first reported a position in BWAY in Q1 2020 and held it in 12 quarters. The position peaked at $14M in Q2 2021. 15 funds tracked by Wall St. Rank hold BWAY as of Q1 2023.

  • Cowen and Company reported no remaining Brainsway position as of Q1 2023 after selling out during the quarter.
  • Cowen and Company sold 690,002 Brainsway shares in Q1 2023, an estimated $852K.
  • Cowen and Company first reported a position in Brainsway in Q1 2020 and held it in 12 quarters.
  • Cowen and Company's Brainsway position peaked at $14M in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Brainsway as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.